These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 2136705

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L, Teitler M, Fletcher PW, Ismaiel AM, Glennon RA.
    Brain Res; 1990 Nov 05; 532(1-2):191-6. PubMed ID: 2282513
    [Abstract] [Full Text] [Related]

  • 5. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
    Schlegel JR, Peroutka SJ.
    Biochem Pharmacol; 1986 Jun 15; 35(12):1943-9. PubMed ID: 3013203
    [Abstract] [Full Text] [Related]

  • 6. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.
    Herrick-Davis K, Titeler M.
    J Neurochem; 1988 Feb 15; 50(2):528-33. PubMed ID: 2961850
    [Abstract] [Full Text] [Related]

  • 7. Preservation of 5-hydroxytryptamine1A receptor-G protein interactions in the cerebral cortex of patients with Alzheimer's disease.
    O'Neill C, Cowburn RF, Wiehager B, Alafuzoff I, Winblad B, Fowler CJ.
    Neurosci Lett; 1991 Nov 25; 133(1):15-9. PubMed ID: 1838799
    [Abstract] [Full Text] [Related]

  • 8. Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
    Kitamura Y, Imai S, Matsueda R, Nomura Y.
    Mol Pharmacol; 1990 Aug 25; 38(2):184-91. PubMed ID: 2166901
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
    Nénonéné EK, Radja F, Carli M, Grondin L, Reader TA.
    J Neurochem; 1994 May 25; 62(5):1822-34. PubMed ID: 8158133
    [Abstract] [Full Text] [Related]

  • 10. Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins.
    Emerit MB, el Mestikawy S, Gozlan H, Rouot B, Hamon M.
    Biochem Pharmacol; 1990 Jan 01; 39(1):7-18. PubMed ID: 2136995
    [Abstract] [Full Text] [Related]

  • 11. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA, Davis KH, Titeler M.
    Mol Pharmacol; 1987 Feb 01; 31(2):194-9. PubMed ID: 3543649
    [Abstract] [Full Text] [Related]

  • 12. Mg2+ enhances high affinity [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding and guanine nucleotide modulation of serotonin-1a receptors.
    DeVinney R, Wang HH.
    J Recept Signal Transduct Res; 1995 Apr 01; 15(5):757-71. PubMed ID: 8747885
    [Abstract] [Full Text] [Related]

  • 13. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M.
    Eur J Pharmacol; 1995 Jan 16; 288(2):173-86. PubMed ID: 7720779
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
    Hall MD, Gozlan H, Emerit MB, el Mestikawy S, Pichat L, Hamon M.
    Neurochem Res; 1986 Jun 16; 11(6):891-912. PubMed ID: 3016581
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological and biochemical characterization of rat hippocampal 5-hydroxytryptamine1A receptors solubilized by 3-[3-(cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS).
    el Mestikawy S, Cognard C, Gozlan H, Hamon M.
    J Neurochem; 1988 Oct 16; 51(4):1031-40. PubMed ID: 2971097
    [Abstract] [Full Text] [Related]

  • 16. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
    Yokota N, Yamawaki S, Hayakawa H, Yoshida R, Sarai K.
    Yakubutsu Seishin Kodo; 1989 Jun 16; 9(2):197-206. PubMed ID: 2530729
    [Abstract] [Full Text] [Related]

  • 17. Further characterisation of [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding sites in human brain postmortem.
    Palego L, Marazziti D, Rotondo A, Batistini A, Lucacchini A, Naccarato AG, Bevilacqua G, Borsini F, Ladinsky H, Cassano GB.
    Neurochem Int; 1997 Feb 16; 30(2):149-57. PubMed ID: 9017662
    [Abstract] [Full Text] [Related]

  • 18. Potency of 5-hydroxytryptamine1a agonists to inhibit adenylyl cyclase activity is a function of affinity for the "low-affinity" state of [3H]8-hydroxy-N,N-dipropylaminotetralin ([3H]8-OH-DPAT) binding.
    Chamberlain J, Offord SJ, Wolfe BB, Tyau LS, Wang HL, Frazer A.
    J Pharmacol Exp Ther; 1993 Aug 16; 266(2):618-25. PubMed ID: 8355195
    [Abstract] [Full Text] [Related]

  • 19. CHAPS solubilization of a G-protein sensitive 5-HT1A receptor from bovine hippocampus.
    Kline T, Park H, Meyerson LR.
    Life Sci; 1989 Aug 16; 45(21):1997-2005. PubMed ID: 2532283
    [Abstract] [Full Text] [Related]

  • 20. Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein.
    Zemlan FP, Schwab EF.
    J Neurochem; 1991 Dec 16; 57(6):2092-9. PubMed ID: 1834802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.